IGMS
IGM Biosciences
IGMS
IGMS
Delisted
IGMS was delisted on the 13th of August, 2025.
79 hedge funds and large institutions have $186M invested in IGM Biosciences in 2023 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 27 increasing their positions, 21 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
79
Holders Change
–
Holders Change %
0%
% of All Funds
1.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
27
Reduced
21
Closed
14
Calls
$145K
Puts
$9K
Net Calls
+$136K
Net Calls Change
+$76K
Top Buyers
| 1 |
ECM
ExodusPoint Capital Management
New York
|
+$3.79M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.69M |
| 3 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$1.65M |
| 4 |
First Manhattan
New York
|
+$1.44M |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$1.04M |
Top Sellers
| 1 |
UBS AM
Chicago,
Illinois
|
-$3.96M |
| 2 |
Millennium Management
New York
|
-$1.81M |
| 3 |
Goldman Sachs
New York
|
-$1.8M |
| 4 |
D.E. Shaw & Co
New York
|
-$832K |
| 5 |
Renaissance Technologies
New York
|
-$711K |
